CVS soars after fourth-quarter profit signals improvement
CVS is trying to turn around its drugstore chain and insurance business. The company spent a smaller percentage of premium revenue on medical expenses than analysts expected.
CVS Health steers through rising insurance costs in a strong fourth quarter
CVS Health’s adjusted fourth-quarter profit handily beat Wall Street’s estimates, even as the drugstore chain and pharmacy benefits manager dealt with rising costs in its insurance division
CVS Earnings: CVS Health Stock Jumps as Earnings Beat Despite Higher Insurance Payouts
Troubled drugstore chain CVS Health (CVS) reported Fiscal fourth-quarter results that beat on the top and bottom lines, sending shares sharply
CVS Health beats quarterly profit estimates on lower medical costs
CVS Health reported a smaller-than-expected drop in fourth-quarter profit on Wednesday as its pace of medical cost increases slowed and revenue at its pharmacy business jumped, sending its shares up more than 12% in premarket trading.
CVS Health 2024 Profits Eclipse $4.6 Billion Despite Rising Costs
CVS Health reported $4.6 billion in 2024 profit including $1.6 billion in the fourth quarter as its health insurance business works to overcome rising medical expenses.
Morning Movers: CVS Health jumps following fourth quarter earnings
Check out this morning’s top movers from around Wall Street, compiled by The Fly. Maximize Your Portfolio with Data Driven
CVS Health steers through rising insurance costs in strong fourth quarter
CVS Health steered through rising costs in its insurance division to handily beat profit expectations on Wall Street.
CVS Health Beats Fourth-Quarter Estimates, Projects Annual Earnings Growth in 2025
CVS Health (CVS) reported better-than-expected fourth-quarter results on Wednesday, while the healthcare company projected higher 2025 earnings on a year-over-year basis. Adjusted earnings came in at $1.
CVS stock rises 10% as company beats revenue estimates despite insurance cost pressures
CVS Health (NYSE: CVS) reported fourth-quarter earnings that exceeded analyst expectations on Wednesday, driven by strong sales in its pharmacy and insurance businesses. However, the company continues to face rising medical costs in its insurance unit,
CVS’s stock is having its best day since 1999, after more than just earnings
CVS’s stock soared toward after its quarterly profit beat expectations by the widest margin in more than four years.
CVS shares pop 15% on big earnings beat, even as high medical costs drag down insurance unit
It caps off the first full quarter with David Joyner, a longtime CVS executive, as CEO of the troubled retail drugstore chain ...
CVS Health Stock Jumps on Earnings Beat and Solid Guidance. ‘Phew!’ Says One Analyst.
CVS Health investors were breathing a big sigh of relief Wednesday after the healthcare services behemoth reported ...
Top Analysts Upgrade CVS Health Stock (CVS) after Upbeat Q4 Results
CVS Health (CVS) stock soared about 15% yesterday after posting upbeat fourth-quarter results, with revenues and earnings surpassing analysts’ ...
CVS Beats EPS Estimates, Losses Loom
The earnings surpassed analyst expectations with an adjusted earnings per share (EPS) of $1.19, beating estimates of $0.91 by ...
Fierce Healthcare15h
CVS CEO Joyner mounts defense of PBM industry amid ongoing scrutiny
CVS Health reported $1.6 billion in profit for the fourth quarter, down from a $2 billion haul a year ago, according to its ...
Which companies have the best loyalty and rewards programs? CVS, Kroger, Kohl's made the list
Kroger, CVS, and Kohl's are among the 350 companies with the best loyalty and rewards programs, according to new research ...
Modern Healthcare22h
CVS soars after Q4 profit signals improvement
Adjusted earnings for 2025 will be $5.75 to $6 a share, CVS said, while the average estimate of analysts surveyed by ...
Five things: Biogen, CVS, Eastern Nazarene, spring training, Rat Day, and more Valentine’s ideas
Good morning, Boston. Spring training has begun, and here are the five things you need to know, including Biogen cutbacks, CVS's new CEO, Eastern Nazarene sale, spring training, Rat Day, and more Vale ...